newsfilter
← Latest News
Business Wire·

Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions

Validated engines and AI-orchestrated ecosystem align with the emerging regulatory framework Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and